Hae

Tulokset

Näytetään 3 / 3 tulokset

Scientific evidence indicates that beneficial microorganisms (that live in nearly ubiquitous communities called microbiota) are an essential component of human health, and could be a new frontier for personalised medicine to fight non-communicable diseases and improve human health. For their potential benefits to reach society, the EU should consider standardisation, protocols, and a regulatory framework to support research and innovation.

Synthetic biology is a new dimension of modern biotechnology with the potential to design and manufacture living organisms, components and products. It will be on the agenda of the 13th meeting of the Conference of the Parties (COP) of the United Nations Convention on Biological Diversity (CBD), to be held from 4 to 17 December 2016, in Cancún, Mexico. Synthetic biology could provide novel solutions for environmental and biodiversity-related issues, but could also have an adverse impact on the natural ...

The rise of antimicrobial resistance – when bacteria and other microorganisms become resistant to the treatments used against the infections they cause – is a pressing public health issue. Cross-sector efforts, particularly awareness-raising, are being intensified, both in the EU and globally. This 'At a glance' note updates an earlier version of June 2015: PE 559.484.